相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Basis of Small-Molecule Binding to alpha-Synuclein
Paul Robustelli et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)
Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis
Phuong H. Nguyen et al.
CHEMICAL REVIEWS (2021)
Sequence Determines the Switch in the Fibril Forming Regions in the Low-Complexity FUS Protein and Its Variants
Abhinaw Kumar et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2021)
α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques
Nicolo Bisi et al.
FRONTIERS IN CHEMISTRY (2021)
Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein
Ming-ming Xu et al.
ACTA PHARMACOLOGICA SINICA (2020)
Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease
Fatima Kamal Zaidi et al.
BIOCHEMICAL JOURNAL (2020)
Natural and Synthetic Derivatives of Hydroxycinnamic Acid Modulating the Pathological Transformation of Amyloidogenic Proteins
Vladimir I. Muronetz et al.
MOLECULES (2020)
Protein Interaction with Charged Macromolecules: From Model Polymers to Unfolded Proteins and Post-Translational Modifications
Pavel Semenyuk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation
Valentina Oliveri
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles
Richard M. Meade et al.
MOLECULAR NEURODEGENERATION (2019)
Full atomistic model of prion structure and conversion
Giovanni Spagnolli et al.
PLOS PATHOGENS (2019)
Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species
Priyanka Singh et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Computational models explain how copper binding to amyloid-β peptide oligomers enhances oxidative pathways
Giovanni La Penna et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2019)
Molecular dynamics simulations and novel drug discovery
Xuewei Liu et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Ensemble Docking in Drug Discovery
Rommie E. Amaro et al.
BIOPHYSICAL JOURNAL (2018)
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Jessika C. Bridi et al.
FRONTIERS IN NEUROSCIENCE (2018)
A new era for understanding amyloid structures and disease
Matthew G. Iadanza et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
CHARMM36m: an improved force field for folded and intrinsically disordered proteins
Jing Huang et al.
NATURE METHODS (2017)
Dimerization of Tyr136Cys alpha-synuclein prevents amyloid transformation of wild type alpha-synuclein
K. V. Barinova et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
The Synucleinopathies: Twenty Years On
Michel Goedert et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Amino acid substitutions [K16A] and [K28A] distinctly affect amyloid β-protein oligomerization
Matjaz Zganec et al.
JOURNAL OF BIOLOGICAL PHYSICS (2016)
Review: The spectrum of clinical features seen with alpha synuclein pathology
R. A. Barker et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)
Versatile Structures of α-Synuclein
Chuchu Wang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease
Lars Tatenhorst et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Anti-fibrillation potency of caffeic acid against an antidepressant induced fibrillogenesis of human α-synuclein: Implications for Parkinson's disease
Naveed Ahmad Fazili et al.
BIOCHIMIE (2015)
Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies
Jessica Nasica-Labouze et al.
CHEMICAL REVIEWS (2015)
Ceftriaxone Blocks the Polymerization of alpha-Synuclein and Exerts Neuroprotective Effects in Vitro
Paolo Ruzza et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Automation of the CHARMM General Force Field (CGenFF) II: Assignment of Bonded Parameters and Partial Atomic Charges
K. Vanommeslaeghe et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Determination of the Free Energy Landscape of α-Synuclein Using Spin Label Nuclear Magnetic Resonance Measurements
Jane R. Allison et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Structural and mechanistic basis behind the inhibitory interaction of PcTS on α-synuclein amyloid fibril formation
Gonzalo R. Lamberto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A temperature predictor for parallel tempering simulations
Alexandra Patriksson et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2008)
Principles of flexible protein-protein docking
Nelly Andrusier et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Neuropathology, biochemistry, and biophysics of α-synuclein aggregation
Vladimir N. Uversky
JOURNAL OF NEUROCHEMISTRY (2007)
Elucidating amyloid β-protein folding and assembly:: A multidisciplinary approach
David B. Teplow et al.
ACCOUNTS OF CHEMICAL RESEARCH (2006)
Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of α-synuclein
EN Lee et al.
BIOCHEMISTRY (2004)
NMR of α-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation
CO Fernández et al.
EMBO JOURNAL (2004)
Cellular polyamines promote the aggregation of α-synuclein
T Antony et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein -: A possible molecular link between Parkinson's disease and heavy metal exposure
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
